Implantable cardiac monitors (ICMs) continuously monitor the patient's electrocardiogram and perform real-time analysis of the heart rhythm, for up to 36 months. The current clinical use of ICMs ...

The transient nature of syncope makes its evaluation challenging. After an initial history, physical examination, and electrocardiogram, the cause of syncope can remain unexplained in up to 47% of ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Cardiac electrophysiologist Dr. Jonathan Piccini says Medtronic's Define AFib study offers important lessons for other device ...

Glucotrack (Nasdaq:GCTK) announced that it expects FDA investigational device exemption for its long-term CBGM later this ...

GlucoTrack is a medical technology company whose two-year implantable Continuous Blood Glucose Monitoring (CBGM) technology provides discreet, accurate, real-time glucose readings.

Wearable and implantable biosensors that can accurately detect biological molecules in a non- or minimally invasive manner have vast potential for monitoring patients' physiology and response to ...

After fainting unexpectedly in 2020, a woman from Ayodhya sought extensive medical help to determine the cause. Eventually, a ...

Paul Goode, President & CEO, GlucoTrack GCTK, was recently a guest on Benzinga's All-Access. GlucoTrack is a medical technology company whose two-year implantable Continuous Blood Glucose ...